Logo

Fujirebio Lumipulse G ApoE4 and G Pan-ApoE Assays

Mar 31, 2023

Fujirebio has launched the Lumipulse G ApoE4 and G Pan-ApoE Assays for research use only on the fully automated Lumipulse G Systems. These chemiluminescent enzyme immunoassays enable the quantitative measurement of the E4 isoform of the apolipoprotein E (ApoE4), specifically, and for all isoforms of the same protein (Pan-ApoE), respectively, in human plasma within just 35 minutes. The company said that researchers can use the assays to further investigate the clinical utility of ApoE protein quantification in Alzheimer's disease and related disorders on the Lumipulse G. This platform has the required throughput and meets the regulatory requirements to support possible future routine use of blood-based testing of these markers, Fujirebio added.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.